Patents Assigned to ONCO-PHARMAKON INCORPORATED
  • Publication number: 20090118349
    Abstract: The present invention relates to (i) conjugates comprising two DNA alkylating subunits linked by a moiety fitting to the minor groove of the DNA, (ii) to their preparation and (iii) to their use in cancer therapy. The alkylating subunits are especially cytotoxic under hypoxic conditions found in cancer cells. The compounds of the present invention and compositions thereof are useful in the treatment of cancer in a mammal, both alone or in a combination with other anti-cancer agents (e.g. checkpoint abrogators) and/or radiation. They may also be used as cytotoxic units for gene-directed enzyme-prodrug therapy (GDEPT) and antibody-directed enzyme-prodrug therapy (ADEPT). The present invention provides the compounds of Formula (I), Formula (II) and Formula (III): for treating cancer in a mammal.
    Type: Application
    Filed: August 16, 2008
    Publication date: May 7, 2009
    Applicant: ONCO-PHARMAKON INCORPORATED
    Inventors: Zoltan Szekely, Matthew Gerard McDonnell